Department of Surgery, University of Iowa, Iowa City, IA.
Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA.
Surgery. 2021 Mar;169(3):617-622. doi: 10.1016/j.surg.2020.09.029. Epub 2020 Oct 22.
Introduction of gut flora into the biliary system is common owing to biliary stenting in patients with obstructing pancreatic head cancer. We hypothesize that alteration of biliary microbiome modifies bile content that modulates pancreatic cancer cell survival.
Human bile samples were collected during pancreaticoduodenectomy. Bacterial strains were isolated from contaminated (stented) bile and identified using 16S ribosomal RNA sequencing. Human pancreatic cancer cells (AsPC1, CFPAC, Panc1) were treated for 24 hours with sterile (nonstented) bile, contaminated (stented) bile, and sterile bile preincubated with 10 colony forming unit of live bacteria isolated from contaminated bile or a panel of bile acids for 24 hours at 37°C, and evaluated using CellTiter-Blue Cell Viability Assay (Promega Corp. Madison, WI). Human bile (30-50 μl/mouse) was coinjected intraperitoneally with 10 Panc02 mouse pancreatic cancer cells in C57BL6/N mice to evaluate the impact of bile on peritoneal metastasis 3 to 4 weeks after tumor challenge.
While all bile samples significantly reduced peritoneal metastasis of Panc02 cells in mice, some contaminated bile samples had diminished antitumor effect. All sterile bile (n = 4) reduced pancreatic cancer cell survival in vitro. Only 40% (2/5) of contaminated bile samples had significant effect. Preincubation of sterile bile with live Enterococcus faecalis or Streptococcus oralis modified the antitumor effect of sterile bile. These changes were not observed with culture media preincubated with live bacteria, suggesting live gut bacteria can modify the antitumor components present in bile. Conjugated bile acids were more potent than unconjugated cholic acid in reducing pancreatic cancer cell survival.
Alteration of bile microbiome from biliary stenting has a direct impact on pancreatic cancer cell survival. Further study is warranted to determine if this microbiome shift alters tumor microenvironment.
由于阻塞性胰头癌患者胆道支架置入,肠道菌群易进入胆道系统。我们假设胆道微生物组的改变会改变胆汁成分,从而影响胰腺癌细胞的存活。
在胰十二指肠切除术中收集人胆汁样本。从污染(支架置入)胆汁中分离细菌菌株,并通过 16S 核糖体 RNA 测序进行鉴定。将无菌(非支架置入)胆汁、污染(支架置入)胆汁和无菌胆汁与从污染胆汁中分离的 10 个菌落形成单位的活细菌或一组胆汁酸在 37°C 下孵育 24 小时,然后用 CellTiter-Blue 细胞活力测定法(Promega 公司,威斯康星州麦迪逊)处理人胰腺癌细胞(AsPC1、CFPAC、Panc1)24 小时,并进行评估。将 30-50 μl/只人胆汁(每只小鼠)与 10 个 Panc02 小鼠胰腺癌细胞一起经腹腔内注射,以评估胆汁对肿瘤攻击后 3-4 周小鼠腹膜转移的影响。
虽然所有胆汁样本均显著降低了小鼠中 Panc02 细胞的腹膜转移,但一些污染胆汁样本的抗肿瘤效果减弱。所有无菌胆汁(n=4)均降低了体外胰腺癌细胞的存活率。只有 40%(2/5)的污染胆汁样本有显著影响。无菌胆汁与活粪肠球菌或链球菌共孵育后,改变了无菌胆汁的抗肿瘤作用。用活细菌预孵育培养基未观察到这些变化,表明肠道细菌可改变胆汁中的抗肿瘤成分。结合型胆汁酸比未结合型胆酸更能降低胰腺癌细胞的存活率。
胆道支架置入导致的胆汁微生物组改变直接影响胰腺癌细胞的存活。需要进一步研究以确定这种微生物组变化是否改变肿瘤微环境。